Wird geladen...
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia
Standard treatment for hairy cell leukemia (HCL) is markedly effective, but the constant decrease in disease-free survival, together with the presence of minimal residual disease (MRD), suggests that few if any are cured. HCL cells in MRD are always strongly CD20+ and CD22+, and also CD25 + unless t...
Gespeichert in:
| Veröffentlicht in: | Leuk Lymphoma |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7435070/ https://ncbi.nlm.nih.gov/pubmed/21599609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.565843 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|